Pfizer STN 50 mg (Sutent 50 mg)

Generic Name: sunitinib

This pill with imprint "Pfizer STN 50 mg" is Brown, Capsule-shape and has been identified as Sutent 50 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Sutent

Generic Name:

sunitinib

Imprint:

Pfizer STN 50 mg

Strength:

50 mg

Color:

Brown

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Multikinase inhibitors
VEGF/VEGFR inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Pfizer U.S. Pharmaceuticals Group

Inactive Ingredients:

mannitol
croscarmellose sodium
povidone k25
magnesium stearate
gelatin
titanium dioxide
ferric oxide red
ferric oxide yellow
ferrosoferric oxide
shellac
propylene glycol
sodium hydroxide
povidone
Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.